false 0001892322 0001892322 2024-04-01 2024-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 1, 2024

 

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

1-2-33, Higashigotanda,

Shinagawa, Tokyo, Japan

   
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code +81-3-6409-6966

 

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On April 1, 2024, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing that, the Company and its Board of Directors has deemed it in the best interest of the Company and stockholders to declare and authorize a dividend on the common stock. The record date for holders of the Common Stock to participate in the dividend is April 26, 2024, and the payment date will be May 3, 2024. The Company also announced that it may issue quarterly dividends going forward, contingent upon the financial results. The four potential annual dividends may be equal to or greater than the current dividend.

 

The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. The information contained in the press release is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 8.01 Other Events.

 

On April 1, 2024, the Board of Directors of the Company declared a quarterly cash dividend on its outstanding shares of common stock of $0.02 per share. The dividend will be payable to shareholders of record as of April 26, 2024 and is expected to be paid on May 3, 2024.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit    
Number   Description
99.1   Press release issued by the registrant on April 1, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 Date: April 1, 2024 HEARTCORE ENTERPRISES, INC.
     
  By: /s/ Sumitaka Yamamoto
    Sumitaka Yamimoto
    Chief Executive Officer

 

3